Trials / Recruiting
RecruitingNCT05316805
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project: a National Multicenter Prospective Cohort Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100,000 (estimated)
- Sponsor
- Peking University First Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
In order to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases, the National Clinical Center for Skin and Immune Diseases established a standardized diagnosis and treatment center for type 2 inflammatory skin diseases to systematically and effectively understand the current treatment status of patients with type 2 inflammatory skin diseases, as well as the efficacy and safety of various treatment methods during practices, so as to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases and help patients with type 2 inflammatory skin diseases.
Conditions
Timeline
- Start date
- 2021-08-31
- Primary completion
- 2031-12-31
- Completion
- 2031-12-31
- First posted
- 2022-04-07
- Last updated
- 2024-08-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05316805. Inclusion in this directory is not an endorsement.